Literature DB >> 19100659

Bacillus cereus heteroresistance to carbapenems in a cancer patient.

V Savini, M Favaro, C Fontana, C Catavitello, A Balbinot, M Talia, F Febbo, D D'Antonio.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 19100659     DOI： 10.1016/j.jhin.2008.11.002

Source DB:  PubMed          Journal:  J Hosp Infect        ISSN： 0195-6701            Impact factor:   3.926


× No keyword cloud information.
  5 in total

Review 1.  Bacillus cereus, a volatile human pathogen.

Authors:  Edward J Bottone
Journal:  Clin Microbiol Rev       Date:  2010-04       Impact factor: 26.132

2.  Carbapenem Heteroresistance in VIM-1-producing Klebsiella pneumoniae isolates belonging to the same clone: consequences for routine susceptibility testing.

Authors:  M Tato; M Morosini; L García; S Albertí; M T Coque; R Cantón
Journal:  J Clin Microbiol       Date:  2010-09-15       Impact factor: 5.948

3.  Genetic diversity and the presence of circular plasmids in Bacillus cereus isolates of clinical and environmental origin.

Authors:  Tjaša Cerar Kišek; Nežka Pogačnik; Karmen Godič Torkar
Journal:  Arch Microbiol       Date:  2021-04-08       Impact factor: 2.552

4.  Relapsing Bacillus cereus peritonitis in a patient treated with continuous ambulatory peritoneal dialysis.

Authors:  Anastasia Spiliopoulou; Evangelos Papachristou; Antigoni Foka; Fevronia Kolonitsiou; Evangelos D Anastassiou; Dimitrios S Goumenos; Iris Spiliopoulou
Journal:  JMM Case Rep       Date:  2014-12-01

5.  Bacillus cereus efflux protein BC3310 - a multidrug transporter of the unknown major facilitator family, UMF-2.

Authors:  Jasmin K Kroeger; Karl Hassan; Aniko Vörös; Roger Simm; Massoud Saidijam; Kim E Bettaney; Andreas Bechthold; Ian T Paulsen; Peter J F Henderson; Anne-Brit Kolstø
Journal:  Front Microbiol       Date:  2015-10-12       Impact factor: 5.640
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.